If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Publisher: Wiley-Blackwell

Related content
Volume 257, Number 1, 1 January 2014

< previous issue | all issues | next issue >

Favourites:Add to Favourites

Preview of Immunological Reviews for 2014
pp. 5-5(1)
Author: Koretzky, Gary

Favourites:Add to Favourites

Video podcast: Adoptive Immunotherapy for Cancer
pp. 6-6(1)
Author: Stadanlick, Justina

Favourites:Add to Favourites

Engineering T cells for cancer: our synthetic future
pp. 7-13(7)
Authors: Vonderheide, Robert H.; June, Carl H.

Favourites:Add to Favourites

Adoptive immunotherapy for cancer
pp. 14-38(25)
Authors: Ruella, Marco; Kalos, Michael

Favourites:Add to Favourites

T lymphocytes targeting native receptors
pp. 39-55(17)
Authors: Rooney, Cliona M.; Leen, Ann M.; Vera, Juan F.; Heslop, Helen E.

Favourites:Add to Favourites

Exploiting the curative potential of adoptive T‐cell therapy for cancer
pp. 56-71(16)
Authors: Hinrichs, Christian S.; Rosenberg, Steven A.

Favourites:Add to Favourites

TCR repertoires of intratumoral T‐cell subsets
pp. 72-82(11)
Authors: Linnemann, Carsten; Mezzadra, Riccardo; Schumacher, Ton N. M.

Favourites:Add to Favourites
Favourites:Add to Favourites

CAR T cells: driving the road from the laboratory to the clinic
pp. 91-106(16)
Authors: Cheadle, Eleanor J.; Gornall, Hannah; Baldan, Vania; Hanson, Vivien; Hawkins, Robert E.; Gilham, David E.

Favourites:Add to Favourites

Design and development of therapies using chimeric antigen receptor‐expressing T cells
pp. 107-126(20)
Authors: Dotti, Gianpietro; Gottschalk, Stephen; Savoldo, Barbara; Brenner, Malcolm K.

Favourites:Add to Favourites

Design and implementation of adoptive therapy with chimeric antigen receptor‐modified T cells
pp. 127-144(18)
Authors: Jensen, Michael C.; Riddell, Stanley R.

Favourites:Add to Favourites

Re‐adapting T cells for cancer therapy: from mouse models to clinical trials
pp. 145-164(20)
Authors: Stromnes, Ingunn M.; Schmitt, Thomas M.; Chapuis, Aude G.; Hingorani, Sunil R.; Greenberg, Philip D.

Favourites:Add to Favourites

Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
pp. 165-180(16)
Authors: Cieri, Nicoletta; Mastaglio, Sara; Oliveira, Giacomo; Casucci, Monica; Bondanza, Attilio; Bonini, Chiara

Favourites:Add to Favourites

A new approach to gene therapy using Sleeping Beauty to genetically modify clinical‐grade T cells to target CD19
pp. 181-190(10)
Authors: Singh, Harjeet; Huls, Helen; Kebriaei, Partow; Cooper, Laurence J. N.

Favourites:Add to Favourites

Human cell‐based artificial antigen‐presenting cells for cancer immunotherapy
pp. 191-209(19)
Authors: Butler, Marcus O.; Hirano, Naoto

Favourites:Add to Favourites

Rapamycin‐resistant effector T‐cell therapy
pp. 210-225(16)
Author: Fowler, Daniel H.

Favourites:Add to Favourites

Genetically engineered donor T cells to optimize graft‐versus‐tumor effects across MHC barriers
pp. 226-236(11)
Authors: Ghosh, Arnab; Holland, Amanda M.; Brink, Marcel R. M.

Favourites:Add to Favourites

Hematopoietic stem cells for cancer immunotherapy
pp. 237-249(13)
Authors: Gschweng, Eric; Oliveira, Satiro; Kohn, Donald B.

Favourites:Add to Favourites

The use of endogenous T cells for adoptive transfer
pp. 250-263(14)
Author: Yee, Cassian

Favourites:Add to Favourites

Uncoupling T‐cell expansion from effector differentiation in cell‐based immunotherapy
pp. 264-276(13)
Authors: Crompton, Joseph G.; Sukumar, Madhusudhanan; Restifo, Nicholas P.

Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more